-
-
Overview
-
Mecillinam is a broad-spectrum β-lactam antibiotic in the penicillin class, specifically an amidinopenicillin. It was first described in 1972 (Lund and Tybring) and was developed by the Danish pharmaceutical company Leo Pharmaceutical Products (now LEO Pharma). The product is effective against Gram-negative bacteria. Mecillinam is slightly soluble in chloroform.
Please contact us at for specific academic pricing.
Background
β-lactams interfere with penicillin binding protein (PBP) activity involved in the final phase of peptidoglycan synthesis. PBP’s catalyze a pentaglycine crosslink between alanine and lysine residues providing additional strength to the cell wall. Without a pentaglycine crosslink, the integrity of the cell wall is severely compromised and ultimately leads to cell lysis and death. Resistance to β-lactams is commonly due to cells containing plasmid-encoded β-lactamases.
-
- Properties
- Applications
-
Overview